Get the Stockscreener App
3.93
1.50%
-0.06
Orasure Technologies Inc stock is traded at $3.93, with a volume of 693.26K.
It is down -1.50% in the last 24 hours and up +2.88% over the past month.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
See More
Previous Close:
$3.99
Open:
$3.99
24h Volume:
693.26K
Relative Volume:
1.43
Market Cap:
$271.05M
Revenue:
$113.02M
Net Income/Loss:
$-75.07M
P/E Ratio:
-3.7691
EPS:
-1.0427
Net Cash Flow:
$-47.88M
1W Performance:
+12.61%
1M Performance:
+2.88%
6M Performance:
+28.43%
1Y Performance:
+21.67%
1-Day Range:
$3.93
$4.12
1-Week Range:
$3.44
$4.12
52-Week Range:
$2.08
$4.58
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.93 | 271.05M | 113.02M | -75.07M | -47.88M | -1.0427 |
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
OraSure Technologies stock falls 1.5 percent as stake emerges - AD HOC NEWS
OraSure Technologies stock gains 8.13 percent on September 23 - AD HOC NEWS
Perspective: First-Void UrineA New Era in Accessible STI Testing - GenomeWeb
Investor group at OraSure Technologies (OSUR) may seek board seats and a possible sale - Stock Titan
Yorkville Advisors Pushes for Changes at OraSure Technologies with 6.4% Stake - TradingView
OraSure Technologies stock gains attention after Q2 2026 turnaround - AD HOC NEWS
OraSure Technologies (OSUR) director reports tax withholding on vested shares - Stock Titan
OraSure (OSUR) Returns To Profit, But Growth Remains Elusive - Yahoo Finance
Orasure Technologies Stock Price Forecast. Should You Buy OSUR? - StockInvest.us
OraSure Technologies stock holds steady as investors look to recent results - AD HOC NEWS
OraSure Technologies (OSUR) Slides 1.5% as Shares Hold Near Key Support LevelHedge Fund Exposure - siam.in
BlackRock Inc. Takes $27.91 Million Position in OraSure Technologies, Inc. $OSUR - marketbeat.com
OSUR Q2 2026 Earnings: EPS Surprise Hits 132.68%, But Shares Slip $0.83EPS Miss Report - vinanet.vn
Private Management Group Inc. Cuts Stake in OraSure Technologies, Inc. $OSUR - MarketBeat
Cannell Capital LLC Purchases New Holdings in OraSure Technologies, Inc. $OSUR - marketbeat.com
3,613,836 Shares in OraSure Technologies, Inc. $OSUR Acquired by Altai Capital Management L.P. - MarketBeat
OraSure (OSUR) Q2 2026 Results: The EPS Result Is Above Expectation; Post-Report: Shares Move 3.74% Up on the DayEarnings Cycle Report - dars.gov.et
Earnings Preview: OSUR to Report Financial Results Post-market on August 05 - Moomoo
Sera Prognostics names a new finance chief as its current one shifts roles - Stock Titan
OraSure (OSUR) Q2 2026 Earnings Call Transcript - AOL.com
OraSure Technologies (NASDAQ:OSUR) Gains FDA Nod for Rapid Antigen Test - Kalkine Media
OraSure Technologies(OSUR) Stock Options Chain | Quotes & News - Moomoo
OraSure Technologies, Inc.: Target Price Consensus and Analysts Recommendations | OSUR | US68554V1089 - marketscreener.com
EP3: Static price chart | OraSure Technologies, Inc. | US68554V1089 - marketscreener.com
OSUR Stock Price, Quote & Chart - ChartMill
OraSure Technologies: Lack Of Near Term Catalysts (NASDAQ:OSUR) - Seeking Alpha
Kaltura, Inc. (OSUR): Neil Gagnon group reports 5.8% ownership stake - Stock Titan
Omeros: Q2 Earnings Snapshot - AOL.com
Enterprise value to EBIT forward of OraSure Technologies, Inc. – BX:EP3 - TradingView
Oramed: Q2 Earnings Snapshot - AOL.com
Dimensional Fund Advisors LP Sells 437,763 Shares of OraSure Technologies, Inc. $OSUR - MarketBeat
Wall Street Zen Upgrades OraSure Technologies (NASDAQ:OSUR) to Hold - MarketBeat
OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
OraSure Technologies (OSUR) Stock Profit Return Faces Cash Flow Doubts - Sahm
OraSure Technologies, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - moomoo.com
ORA SURE TECHNOLOGIES INC 2026: Revenue $30.64M, Net income $6.25M, EPS $0.09— 10-Q Summary - TradingView
OraSure Technologies (NASDAQ: OSUR) swings to Q2 profit as $22.5M obligation falls - Stock Titan
OraSure Technologies Inc (OSUR) Stock News Today - TradingKey
OraSure Technologies | 10-Q: Q2 2026 Earnings Report - Moomoo
OraSure Technologies, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
OraSure Technologies Inc (OSUR) (Q2 2026) Earnings Call Highligh - GuruFocus
OraSure Technologies Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: OraSure tops Q2 2026 revenue forecast, shares jump - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
OraSure Technologies Inc reports results for the quarter ended June 30Earnings Summary - TradingView
OSUR: Q2 revenue and margin beat, with FDA wins and resilient growth despite IntelliQuick delay - TradingView
OraSure: Q2 Earnings Snapshot - marketscreener.com
EARNINGS_CALL_TRANSCRIPT_TITLE_FORMATTED - Yahoo Finance
OraSure reports Q2 2026 revenue $30.6M, GAAP net income $6.2M and improved gross margin - TradingView
OSUR: Q2 revenue up 9.7% sequentially, net income positive, and FDA clearances drive growth - TradingView
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):